Sign In
Buy FLUX
$0.790
-0.0149 (-1.85%)
At Close: Jun 23, 2026
Govt, company mgmt, labour force should work in unison to boost economy: Trade unions
07:42am, Sunday, 28'th Jun 2020
Participating in a web meeting conducted by the National Institute of Personnel Management (NIPM), trade union leaders emphasized that the government, management of companies, and the labour force mus
5 Bonus Battery Stories — Cobalt-Free Batteries, Battery Reuse ...
08:06pm, Saturday, 27'th Jun 2020
Following up on 7 bonus solar + storage articles — very cool stories that we just didn't get to covering in standalone pieces — here are 5 bonus electric vehicle battery stories.
Better Buy: Amgen vs. Bristol Myers Squibb | The Motley Fool
05:38pm, Saturday, 27'th Jun 2020
Here's how these two drugmakers stack up against each other.
Nektar Therapeutics (NASDAQ: NKTR) Q1 2020 Earnings Call Transcript | AlphaStreet
03:08pm, Friday, 26'th Jun 2020
Final earnings conference call transcript of Nektar Therapeutics - NKTR stock
AnHeart Therapeutics Announces Acceptance of Taletrectinib Phase 1 Data for Publication in Clinical Cancer Research
02:01pm, Friday, 26'th Jun 2020COVID-19 and cancer: can pharma stymie the pandemic’s impact on mortality? -
10:51am, Thursday, 25'th Jun 2020
The COVID-19 pandemic may lead to increased cases of cancer mortality – what can biopharma companies do to help lessen the impact?
Dubai Chamber Launches Business Mentoring and Support Program To Help SMEs Navigate Impacts Of COVID-19
02:00am, Thursday, 25'th Jun 2020
Dubai Chamber's Business Mentoring and Support Program pairs corporations with SMEs that require ongoing support and mentorship as they address new challenges from the COVID-19 crisis.
Myelodysplastic Syndromes: Opportunity Analysis and Forecasts to 2028 - ResearchAndMarkets.com
12:00am, Thursday, 25'th Jun 2020
The
FDA panel to review GlaxoSmithKline multiple myeloma drug next month
04:55pm, Wednesday, 24'th Jun 2020
The drug, belantamab mafodotin, could become the first approved therapy for multiple myeloma that targets the cell-surface antigen BCMA. The FDA accepted the application for the drug in January.
Vornado Realty Trust (NYSE: VNO) Q1 2020 Earnings Call Transcript | AlphaStreet
02:19pm, Wednesday, 24'th Jun 2020
Final earnings conference call transcript of Vornado Realty Trust - VNO stock
Dubai Chamber launches CSR programme to aid SMEs in the emirate
10:09am, Wednesday, 24'th Jun 2020
SMEs will be paired with large companies who will offer professional advice and resources tailored to its specific needs
BMS launches digital Advocacy Exchange for patient groups affected by COVID-19 -
10:00am, Wednesday, 24'th Jun 2020
Bristol Myers-Squibb and digital health firm GRYT Health have teamed up to develop an ‘Advocacy Exchange’ virtual platform to unite patient advocacy organisations, patients, policy makers, healthc
Brother Unveils New ‘On the Go-Ready’ Line of Mobile Receipt Printers
10:00am, Tuesday, 23'rd Jun 2020
New pocket-sized, easy-to-pair RuggedJet Go is designed to meet urgent demand for efficient and affordable printing at the point of sale or serviceWESTMINSTER, Colo. — Brother Mobile Solution…
